Patient-controlled Analgesic Pumps Market Size Worth $455.6 Million By 2028 | CAGR: 5.7%

Patient-controlled Analgesic Pumps Market Size Worth $455.6 Million By 2028 | CAGR: 5.7%

The global patient-controlled analgesic pumps market size is expected to reach USD 455.6 million by 2028 according to a new study by Polaris Market Research. The report “Patient-controlled Analgesic Pumps Market Share, Size, Trends, Industry Analysis Report, By Type (Electronic, Mechanical); By Application; By End-Use; By Region; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.


The major driving factors for the upward growth of the global market include the increase in the number of cancer cases along with an increase in the incidence of chronic diseases such as arthritis and chronic pain. The increasing adaption of controlled analgesic pumps in managing acute postoperative pain is expected to contribute to the market growth.


Cancer cases are on the rise globally, with 19.3 million cases detected in 2020. In Europe, 3.9 million new cancer cases were diagnosed in 2018. The product is used to administer opioid drugs such as morphine, tramadol, and fentanyl to manage the pain in cancer patients. The number of people suffering from chronic pain and the increase in the number of surgeries will also drive the growth of the industry.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:


COVID-19 pandemic is disrupting the growth of many products related to healthcare globally. Still, the industry is expected to face minimal damage to the growth due to the emergence of a pandemic. Patients with cancer and other chronic pain are expected to use the product under doctors' recommendations in the home care setup.


Since many surgeries are being postponed, the usage of PCA pumps for post-surgical pain management may see a slight slump during the pandemic time. Industry participants include B. Braun Melsungen AG, Smiths Group plc, Baxter International Inc., Micrel Medical, Ace Medical, Becton, Dickinson and Company, ICU Medical, and Fresenius SE & Co. KGaA are some of the key players operating in the global industry.


Polaris Market Research has segmented the patient-controlled analgesic pumps market report on the basis of type, application, end-use, and region:

Patient-controlled Analgesic Pumps, Type Outlook (Revenue - USD Million, 2016 – 2028)

  • Electronic
  • Mechanical

Patient-controlled Analgesic Pumps, Application Outlook (Revenue - USD Million, 2016 – 2028)

  • Diabetes
  • Gastroenterology
  • Hematology
  • Oncology
  • Others

Patient-controlled Analgesic Pumps, End Use Outlook (Revenue - USD Million, 2016 – 2028)

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

Patient-controlled Analgesic Pumps, Regional Outlook (Revenue - USD Million, 2016 – 2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Austria
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Indonesia
    • Malaysia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • Israel
    • Saudi Arabia
    • South Africa
    • UAE